Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Indolent Lymphoma: Is "Watch and Wait" Really "Worry and Wait"? A Patient-Reported Outcomes Study

NCT07173790 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT07173790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07173790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Indolent Lymphoma: Is "Watch and Wait" Really "Worry and Wait"? A Patient-Reported Outcomes Study
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
October 1, 2025
Completion date
September 10, 2027
Enrollment
250 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia (cll) / small lymphocytic lymphoma (sll), follicular lymphoma, grade 1, follicular lymphoma, grade 2, lymphoplasmacytic lymphoma, marginal zone lymphoma(mzl), waldenström macroglobulinemia (wm)